News Archive

WHO - WHO issues urgent call for global climate action to create resilient and sustainable health systems

25th May 2023

Today (24th May) at the World Health Organization (WHO), panelists made an impassioned plea for urgent climate action as it hosted a Strategic Roundtable on the Role of the Health Communities in Climate Action: taking stock and moving forward at the World Health Assembly.

Read More+

ICH - ICH E6(R3) Principles, Annex 1 and Annex 2

23rd May 2023

ICH-E6(R3): An Important Global Good Clinical Practice Standards - Available for Public Input.

Read More+

EMA - Annual report 2022 published

17th May 2023

EMA published its annual report 2022 on 15th May 2023. The report provides an overview of the Agency’s activities to protect and promote public and animal health in the European Union (EU).

Read More+

EMA - 3-year work plan for the Quality domain

17th May 2023

The GMDP IWG 3-year workplan is developed with a focus on the Network Strategy and Regulatory Science Strategy (RSS) goals, with a particular emphasis on supply chain integrity and resilience, product quality and the impact of new manufacturing technologies on the supply chain.

Read More+

EMA - CTIS newsflash – 12 May 2023

17th May 2023

This regular CTIS newsflash provides key updates on CTIS and links to useful reference materials.

Read More+

EMA - Human Medicines Highlights Newsletter 169

17th May 2023

Edition 169

Read More+

EMA - Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 10 - 12 May 2023

17th May 2023

Highlights from 10 - 12 May 2023 meeting

Read More+

EMA - eAF-PMS NEWSLETTER 3

17th May 2023

News, views and interviews for the informed stakeholder. Published four times a year by the European Medicines Agency

Read More+

EMA - recommendations for industry on good practices to ensure continuity in the supply of human medicines, prevent shortages and reduce their impact

17th May 2023

EMA has published recommendations for industry on good practices to ensure continuity in the supply of human medicines, prevent shortages and reduce their impact. Medicine shortages are a global health problem and are increasingly affecting European countries. Shortages can lead to medicine rationing and delay in critical treatments, with a significant impact on patient care. In addition, patients may need to use less effective alternatives and face an increased risk of medication errors. Ensuring the availability of authorised medicines in the European Union (EU) is a key priority for EMA and the European medicines regulatory network.

Read More+

MHRA - Medical device stand-alone software including apps

17th May 2023

MHRA have updated 'Medical device stand-alone software including apps' to include information on the implementation of new regulations, updates to various links including MORE and new software vigilance guidance.

Read More+